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1. Introduction 
Over the past six decades, tourism has experienced continued expansion and diversification 
becoming one of the largest and fastest growing economic sectors in the world. Many new 
destinations have emerged alongside the traditional ones of Europe and North America. In 
the next years an increase of travelling is expected, and the number of related infections will 
also be higher (http://www.unwto.org/facts/menu.html). Rickettsioses are an important 
chapter in the field of travel medicine.  
Rickettsiae are small gram-negative intracellular bacteria (belonging to the alpha-1 
proteobacteria) mainly transmitted by arthropods (lice, fleas, ticks and other acari) with two 
genera: Orientia with a unique specie (Orientia tsutsugamushi) and Rickettsia with several 
species. The clinical pictures that they cause are named rickettsioses (Raoult, 2010a). 
Rickettsioses have been a threat all along the History and nowadays they are an important 
cause of morbi-mortality in some areas of the world. To know the distribution of the 
different diseases caused by these bacteria and how the clinical pictures are recognized may 
be essential for a quick diagnoses and starting the correct treatment. Some of these infections 
can be also easily prevented with basic rules. Main rickettsioses with their distribution area 
are showed in the table 1.  
In the 21st Century in most parts of the world hygienic conditions have improved and 
epidemic typhus is absent. To acquire this condition it is necessary to be in contact with 
body lice. Furthermore, if people have personal hygiene and change their clothing, body lice 
are removed. Nevertheless it is possible that if we travel for cooperation to catastrophic 
areas or other places with poverty, we may take body lice (refugees’ camps) and may 
develop exanthematic typhus.  
There are a lot of references of rickettsioses acquired by travellers and considered imported 
diseases (McDonald et al., 1988; Bottieau et al. 2006; Freedman et al., 2006; Askling et al. 
2009; Chen & Wilson, 2009; Jensenius et al., 2009; Stokes & Walters, 2009).  
Nowadays ticks cause most travel-associated rickettsioses. Ticks are considered to be one of 
the most important vectors of infectious diseases in the world, preceded only by 
mosquitoes. Therefore, tick-borne rickettsioses are endemic all over the world (Hechemy et 
al., 2006). The majority of travel-associated rickettsioses refer to Sub-Saharan Africa tourists 
who develop African tick-bite fever (ATBF), mainly transmitted by Amblyomma hebraeum 
(Figure 1). In addition to malaria, ATBF is an important cause of fever in people returning 
from the tropic (Field et al., 2010). Other reports describe Mediterranean spotted fever (MSF) 
acquired by tourists bitten by Rhipicephalus spp. ticks (Figure 2) when visiting Europe, being 
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more scarce references about other rickettsioses. Flea-borne rickettsioses and chigger-
transmitted rickettsioses are less frequent in travellers and tourists, and some of them as 
murine typhus are associated with poor hygienic conditions. Most travel-acquired 
rickettsioses are related to outdoors leisure activities, like camping, trekking, hunting, 
safaris, etc.  
It will be impossible to describe all rickettsioses in few pages. Since rickettsioses have very 
similar clinical pictures and they can be grouped in different syndromes, we will describe 
these syndromes emphasizing the typical features (i.e.: Presence of eschar or type of rash). 
Afterwards, distribution can be observed in the table 1. We will also write a specific 
paragraph for some infections (i.e.: Diseases caused by Rickettsia akari and Orientia 
tsutsugamushi).  
 
 
 
 
 
Fig. 1. Amblyomma hebraeum, the principal vector of African-tick bite fever (ATBF) in 
southern Africa. 
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Fig. 2. Rhipicephalus spp., the main vector of Mediterranean spotted fever (MSF). 
 
DISEASE CAUSATIVE 
AGENT
VECTOR DISTRIBUTION 
Epidemic typhus R. prowazekii Body lice (Pediculus 
humanus corporis) 
Peru, northern Africa, 
Senegal, Burundi, 
Rwanda, Russia, 
sporadic cases in USA 
associated with flying 
squirrels. Potentially, all 
over the world 
associated to poverty 
and dirt. 
Murine typhus R. typhi Fleas (Xenopsylla 
cheopis and 
Ctenocephalides felis)
All over the world (more 
prevalent in tropical and 
subtropical areas) 
Flea-borne spotted 
fever 
R. felis Cat fleas 
(Ctenocephalides felis)
All over the world 
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DISEASE CAUSATIVE 
AGENT
VECTOR DISTRIBUTION 
Scrub typhus Orientia 
tsutsugamushi 
Trombiculid mite 
larvae (chiggers) 
Thailand, Laos, India, 
Pakistan, Kashmir, Sri-
Lanka, Afghanistan, 
Nepal, China, Japan, 
Korea, Indonesia. 
Philippines, Papua-New 
Guinea, Australia 
Rickettsialpox R. akari Mouse mites 
(Liponyssoides sanguineus)
Eastern Europe, Korea, 
South Africa, USA 
RMSF1 R. rickettsii Dermacentor variabilis
and other American 
ticks 
USA, Mexico, Colombia, 
Brazil, Argentina, 
Panama, Costa Rica 
RMSF-like R. parkeri Amblyomma spp. ticks USA, Uruguay, Brazil, 
Argentina 
MSF2 R. conorii conorii,
R. conorii israelensis,
R. conorii caspia, 
R. conorii indica
Rhipicephalus spp. ticks Mediterranean area, 
Central Europe, Russia, 
India and Africa 
MSF-like R. monacensis Ixodes ricinus ticks Europe 
MSF-like R. massiliae Rhipicephalus 
sanguineus ticks 
Mediterranean area, 
Argentina, USA? 
MSF-like R. aeschlimannii Hyalomma marginatum
ticks
Africa, Europe? 
DEBONEL / 
TIBOLA2 
R. slovaca
R. rioja 
R. raoultii
Dermacentor marginatus 
ticks 
Europe 
LAR4 R. sibirica 
mongolitimonae 
Hyalomma spp. and 
Rhipicephalus pusillus ticks
Europe, Africa. 
ATBF5 R. africae Amblyomma spp. ticks Sub-Saharan Africa and 
West Indies 
Siberian tick 
typhus 
R. sibirica sibirica Dermacentor spp. ticks Russia, Pakistan, China 
R. helvetica 
infection 
R. helvetica Ixodes ricinus ticks Central and northern 
Europe, Asia 
Japanese spotted 
fever 
R. japonica Ticks Japan 
Queensland tick 
typhus 
R. australis Ixodes spp. ticks Eastern Australia 
Flinder’s Island 
spotted fever 
R. honei Ticks Australia, Southeast Asia 
Far Eastern spotted 
fever 
R. heilonjgiangensis Dermacentor spp. ticks Eastern Asia 
1RMSF: Rocky Mountain spotted fever; 2MSF: Mediterranean spotted fever; 3DEBONEL/TIBOLA: 
Dermacentor-borne, necrosis, erythema, lymphadenopathy/Tick-borne lymphadenopathy; 4LAR: 
Lymphangitis-associated rickettsiosis; 5ATBF: African tick-bite fever. 
Table 1. Rickettsia spp. causing medical diseases, vectors and distribution 
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2. Typhus syndrome 
Typhus syndrome refers to a febrile syndrome with mental status impairment and rash. It is 
caused by Rickettsia prowazekii (epidemic typhus) and Rickettsia typhi (formerly, R. mooseri). 
Rickettsia felis may also produce a typhus syndrome named flea-borne spotted fever, which 
is similar to R. typhi infection (perhaps less severe) (Walker & Raoult, 2010; Dumler & 
Walker 2010; Oteo et al., 2006).  
Nowadays epidemic typhus is only present in some regions of Africa, Russia and in Peru. It 
is associated with bad hygienic conditions that are necessary for body lice parasitization. 
Sporadic cases associated with contact with flying squirrels and their parasite arthropods, 
which have been involved as new reservoirs of the infection, have also been reported in 
USA. A possible source of R. prowazekii infection may be a recrudescent case (Brill-Zinsser 
disease) of R. prowazekii infection. If hygienic conditions are altered and an epidemic of body 
lice appears may be an epidemic of typhus, as occurred in Burundi with hundreds of 
affected people (Raoult et al., 1998). Some cases of louse-borne typhus in travellers have 
been published (Zanetti et al., 1998; Kelly et al., 2002).  
Endemic typhus or murine typhus is associated with the presence of fleas. The main vector 
is the rat flea (Xenopsylla cheopis) associated with dirt and poor hygienic conditions. Flea-
borne spotted fever is associated with the cat flea, and in this case bad hygienic conditions 
are not necessary. Murine typhus and flea-borne spotted fever are distributed all over the 
world. Although they are more frequent in tropical and subtropical areas, cases have also 
been reported in the Mediterranean area (Greece, Italy, Spain, France and Portugal) 
(Bernabeu-Wittel et al., 1999; Angel-Moreno et al., 2006; Gikas et al,. 2009; Pérez-Arellano et 
al., 2005; Oteo et al., 2006).  
The clinical pictures of murine typhus and flea-borne spotted fever are less severe than the 
one of epidemic typhus. Thus, 1-2 weeks after the flea exposure, patients begin with fever, 
headache, myalgia, nausea and vomiting. Rash can be difficult to see in some cases, but is 
present until 80%. For R. typhi infection, rash is macular or maculo-papular and typically 
affects trunk and less frequently extremities. In epidemic typhus, petechial rash is more 
frequent than in endemic typhus, and cough, nausea and vomiting are frequent features. On 
the contrary of tick-borne rickettsioses or scrub typhus, an inoculation eschar (tache noire) is 
not observed. In most cases, fever and rash disappear in a few weeks but complications can 
be developed (central nervous, kidney involvement with renal insufficiency, respiratory 
failure, etc.). These complications are more frequent for epidemic typhus and in older 
people or patients suffering chronic diseases (Walker & Raoult, 2010; Dumler & Walker 
2010). In all these conditions a raise in hepatic enzymes, C reactive protein as well as in 
leucocytes and platelets counts can be observed. We can also observe hepatosplenomegaly. 
In severe cases mainly associated with epidemic typhus, evolution to a multiple-organ 
dysfunction syndrome and coagulation disorders may appear.   
Some references related to travellers are: Zanetti et al., 1998; Niang et al., 1999; Kelly et al., 
2002; Jensenius et al., 2004; Azuma et al., 2006; Angelakis et al., 2010; Walter et al., 2011. 
3. Tick-borne spotted fever 
Tick-borne spotted fever are worldwide distributed and the clinical picture is very similar, 
although the severity is different related with the Rickettsia species involved.  
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ATBF and MSF are the most frequent tick-borne spotted fever rickettsioses in travellers 
(Smoak et al., 1996; Fournier et al., 1998; Oteo et al., 2004a; Raoult et al., 2001; Caruso et al., 
2002; Jensenius et al., 2003; Roch et al., 2008; Tsai et al., 2008; Consigny et al., 2009; Stephany 
et al., 2009; Althaus et al., 2010; Jensenius et al., 2004; Boillat et al., 2008; Laurent et al., 2009). 
For this reason, we will refer to these conditions taking into account that few differences in 
the incubation period and severity may exist. For Rocky Mountain spotted fever (RMSF) 
and MSF caused by R. conorii israelensis, higher mortality than with the rest of spotted fever 
rickettsioses has been communicated (de Sousa et al., 2003). Some features of the main 
spotted fever rickettsioses are shown in table 2.  
From 4 to 21 days after the tick bite, fever suddenly starts in 100% cases (less severe in 
ATBF). A characteristic inoculation lesion (eschar) (figure 3) is typically found until 72% of 
MSF cases and until 95% for ATBF. Multiple eschars are observed in some cases. This is 
more frequent in ATBF. Fever is accompanied of chills, headache, etc. (table 2). From 3 to 5 
days after the onset of fever, the rash appears. This is a maculo-papular rash with purpuric 
elements in some cases (figure 4). It is more frequent in extremities and typically affects 
palms and soles. In ATBF the rash can be vesicular (figure 5), as occurs in R. akari and R. 
australis infections. For R. sibirica mongolitimonae infection, known as lymphangitis-
associated rickettsiosis (LAR), lymphangitis from the eschar may appear in approximately  
 
 
Fig. 3. Eschar (tache noire) and maculo-papular rash in a patient with Mediterranean spotted 
fever. 
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50% cases. It also can be observed in ATBF (Figure 6). There are few reported cases of tick- 
borne spotted fever caused by other of Rickettsia species (R. monacensis, R. aeschlimannii, R.  
massiliae, R. helvetica, R. sibirica mongolitimonae, R. parkeri, R. japonica and R. honei, among 
others) but it seems that the clinical pictures are very similar to the one of MSF cases. Data 
about the incidence of these infections among travellers to endemic areas are very scarce 
(Jensenius et al., 2004; Socolovschi et al., 2010). 
For R. helvetica infections rash can be absent and fever is often the unique clinical 
manifestation. All these diseases are more frequent in spring and summer, when the vectors 
are more active. In all these conditions a raise in hepatic enzymes, C reactive protein and in 
leucocytes and platelets counts can be observed. We can also observe hepatosplenomegaly. 
In severe cases mainly associated to RMSF or MSF, evolution to a multiple-organ 
dysfunction syndrome and coagulation disorders may appear. 
Distribution of human cases of tick-borne rickettsioses in Europe, Africa and Americas are 
showed in figures 7-10. Human cases of tick-borne rickettsioses and scrub typhus in Asia 
and Oceania are showed in figure 11. 
 
DISEASE RASH SPECIFITIES ESCHAR FEVER 
MSF1 >95% 10% purpuric rash 72%. Multiple in 32% 
(children) 
100% 
RMSF2 90% 45% purpuric rash <1% 100% 
ATBF3 30% Vesicular rash 100%. Frequently multiple 100% 
DEBONEL/TIBOLA4 Possible Lymph nodes 100%. Larger than in other 
rickettsioses 
30% 
LAR5 >90% 50% lymphangitis Frequent 100% 
R. aeschlimannii 
infection 
Possible - Possible 100% 
R. helvetica infection Possible - Absent Not 
always 
R. massilliae infection Possible Rash can be 
purpuric 
Possible 100% 
R. monacensis 
infection 
Possible - ? 100% 
Queensland tick 
typhus 
100% Vesicular rash 65% 100% 
Flinder’s Island 
spotted fever 
85% 8% purpuric rash 28% 100% 
Siberian tick typhus 100% - 77% 100% 
Japanese spotted 
fever 
100% - 90% 100% 
Far eastern spotted 
fever 
Possible - Possible 100% 
1MSF: Mediterranean spotted fever; 2RMSF: Rocky Mountain spotted fever; 3ATBF: African tick-bite 
fever; 4DEBONEL/TIBOLA: Dermacentor-borne, necrosis, erythema, lymphadenopathy/Tick-borne 
lymphadenopathy; 5LAR: Lymphangitis-associated rickettsiosis. 
Table 2. Main clinical characteristics of tick-borne rickettsioses 
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Fig. 4. Vasculitic rash affecting soles in a patient with Mediterranean spotted fever. 
 
Fig. 5. Vesicular rash in a patient with African-tick bite fever. 
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Fig. 6. Eschar and lymphangitis in a patient with African tick-bite fever. 
 
Fig. 7. Map showing distribution of human cases of tick-borne rickettsioses in Europe. 
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Fig. 8. Map showing distribution of human cases of tick-borne rickettsioses in Africa. 
 
Fig. 9. Map showing distribution of human cases of tick-borne rickettsioses in Latin America. 
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Fig. 10. Map showing distribution of human cases of tick-borne rickettsioses in North 
America. 
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Fig. 11. Map showing distribution of human cases of tick-borne rickettsioses and srub 
typhus in Asia and Oceania. 
4. Eschar and lymphadenopathy 
This clinical syndrome has been recently reported in Europe, where it is named TIBOLA 
(TIck-BOrne LimphAdenopaty) or DEBONEL (DErmacentor-BOrne Necrosis-Erythema-
Lymphadenopathy). R. slovaca, R. rioja and R. raoultii are the etiological agents, and 
Dermacentor marginatus is the main vector. This tick species is distributed all over Europe as 
well as in the North of Africa. Since this rickettsiosis appears in the coldest months of the 
year, the risk of acquisition for the travellers is lower than for the rickettsioses that are 
prevalent in spring and summer. In most cases (>90%) the tick-bite is located on the scalp 
(head) and always in the upper site of the body. After 1-15 days (mean: 4.8 days) of 
incubation period, the characteristic skin lesion starts as a crusted lesion at the site of the 
tick-bite (frequently on the scalp). A honey-like discharge from the lesion is observed in 
some cases. Few days later, a necrotic eschar appears (figure 12). This eschar is usually 
bigger than the one observed in MSF cases, and it is surrounded by an erythema. When the 
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tick-bite is out of the head, the skin lesion resembles the erythema migrans of Lyme disease. 
Other typical manifestation, which is always present when the bite is on the head, is the 
presence of regional and very painful lymphadenopathies.  
On the contrary of other rickettsioses, in DEBONEL/TIBOLA there are not systemic clinical 
signs (or they are rare), such as fever or maculo-papular rash (Oteo et al., 2004b). The clinical 
course is sub-acute and no severe complications have been described.  
 
 
Fig. 12. DEBONEL/TIBOLA patient with the typical crusted lesion on the scalp. 
5. Scrub typhus 
The etiological agent of scrub typhus is Orientia tsutsugamushi, which is transmitted by 
chigger bites (trombiculid mite larvae). It is mainly distributed in Afghanistan, India, 
Pakistan, Sri-Lanka, Kashmir, China, Nepal, Japan, Korea, Vietnam, Indonesia, Laos, 
Philippines, Papua New Guinea and Australia (Figure 11). Cases are mainly observed in 
autumn and spring, in temperate zones where the bite of this arthropod, which is on 
vegetation, is frequent. The incubation period is about 10 or more days and the clinical signs 
and symptoms are similar to typhus syndrome, including the rash which is transient and 
easily missed. A difference with typhus syndrome is the presence of eschar that is frequently 
multiple. The presence of regional lymphadenopathy is also more frequent. The mortality 
can be high despite the correct antimicrobial treatment. Outbreaks related to military 
operations have been reported (Pages et al., 2010). Most travel acquired cases of scrub 
typhus occur in patients returning from Southeast Asia (Jensenius et al., 2004, 2006). 
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6. Rickettsialpox 
Rickettsialpox is a worldwide (North America, Eastern Europe, Korea and southern Africa) 
rickettsiosis caused by Rickettsia akari and transmitted by the bite of the mouse mite 
Lyponyssoides sanguineus. We can consider it a remerging infection since several cases have 
been detected in New York City after September 11 attacks (Paddock et al., 2003). Patients 
have fever, a prominent eschar -which is the best sign of the disease- and rash that, as occurs 
in ATBF and Queensland tick typhus, may be vesicular. Palms and soles are not involved. 
The presence of regional lymphadenopathy is common. Patients recover without treatment 
in most cases (Raoult, 2010b). 
7. Laboratory diagnostic tools  
As occurs for all infectious diseases, the most definitive diagnostic method is the rickettsial 
isolation in culture. The main problem is that Rickettsia spp. are strictly intracellular bacteria, 
conventional growth media cannot be used, and a laboratory with P3 safety level (not 
generally available in clinical microbiology labs) is necessary. Furthermore, culture is not 
very sensitive and the yield decreases when clinical samples are taken after antibiotic 
treatment or when samples are not processed within 24 hours. It is a slow technique that is 
used for research purposes but not for the routine clinical practice. Centrifugation shell-vial 
technique is a commercially available adaptation of cell cultures that is easier to handle, 
faster and less hazardous. Isolation attempts on cell cultures may be performed using buffy 
coat or tissue samples (eschar biopsies when possible). If not processed within 24 h, samples 
must be frozen at -70ºC or in liquid nitrogen. 
Detection of rickettsiae by Giménez or Giemsa staining from blood and tissue samples 
would allow the confirmation of the diagnosis, but these techniques are non-specific and 
their sensitivity is very low.  
In some laboratories molecular biology tools, such as polymerase chain reaction (PCR) and 
sequencing, are also available. PCR-based assays from anticoagulated blood, biopsies and 
arthropod tissue samples targeting Rickettsia spp. genes are quite sensitive and useful for a 
quick diagnosis of these infections. The evaluation of several primer sets for the molecular 
diagnosis of rickettsioses demonstrated that the performance of three sequential PCRs 
(nested or semi-nested ones) allowed the detection and identification of Rickettsia species in 
a high percentage of the samples with previous clinical diagnosis or microbiological 
confirmation (serological analysis) of rickettsiosis (Santibáñez et al., 2011). Blood and tissue 
samples should be stored at -20ºC or lower if PCR-based diagnosis is delayed for more than 
24 hours. The European guidelines for the diagnosis of tick-borne bacterial diseases contain 
useful information for clinicians and microbiologists (Brouqui et al., 2004).  
Indirect diagnostic tests and specifically, immunofluorescence assays (IFA) are considered 
the standard tests. Besides, since most traveller patients are investigated after returning, IFA 
are the most available tools for diagnosis. Acute and convalescent sera (collected 4-6 weeks 
after the onset of the illness) should be taken. In many cases we cannot observe 
seroconvertion but a high titre of antibodies. Cross-reactions among Rickettsia spp. make 
very difficult to definitively identify the causative agent by means of IFA. This can only be 
achieved in reference centres in which different antigens and other serological assays, such 
as western-blot, are available. Serum samples can be preserved at -20ºC or lower for several 
months without significant degradation of antibodies. 
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Ticks removed from patients can be used as tools for the diagnosis of tick-borne 
rickettsioses. The strategy includes the identification of the tick to the species level, and the 
detection or isolation of rickettsias (Table 3). 
 
1. Identification of the ticks to the species level 
2. Detection of bacteria in ticks with the use of staining tests (haemolymph for viable 
ticks; salivary glands if ticks were frozen), or PCR-based methods (using one-half of 
the tick, the other half being kept frozen). PCR may also be done using only ticks that 
stain positive. 
3. Sequencing of the amplified PCR fragment and comparison with available sequences 
in sequence databases. 
4. If there is 100% similarity between the tested sequence and the corresponding sequence 
of a known organism, the presumptive identification is confirmed 
5. If the tested sequence appears to be different from all corresponding sequences 
available, the organism is probably a new strain and should be isolated and 
characterized from the stored frozen part of the tick 
Table 3. Strategy for detecting and/or isolating rickettsias from ticks 
Diagnostic scores with epidemiological, clinical and laboratory tests for some tick-borne 
rickettsioses (ATBF and MSF) have been proposed (Tables 4 and 5). 
 
a. Direct evidence of R. africae infection by culture and ⁄ or PCR 
or 
b. Clinical and epidemiological features highly suggestive of ATBF, such as multiple 
inoculation eschars and ⁄ or regional lymphadenitis and ⁄ or a vesicular rash and ⁄ or 
similar symptoms among other members of the same group of travellers coming back 
from an endemic area (sub-Saharan Africa or French West Indies) 
and 
Positive serology against spotted fever group rickettsiae 
or 
c. Clinical and epidemiological features consistent with a spotted fever group 
rickettsiosis such as fever and ⁄ or any cutaneous rash and ⁄ or single inoculation eschar 
after travel to sub-Saharan Africa or French West Indies 
and 
Serology specific for a recent R. africae infection (seroconversion or presence of IgM ‡ 
1:32), with antibodies to R. africae greater than those to R. conorii by at least two 
dilutions, and ⁄ or a Western blot or cross-absorption showing antibodies specific for R. 
africae 
Table 4. Diagnostic criteria for African-tick bite fever (ATBF). A patient is considered to have 
ATBF when criteria A, B or C are met 
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CRITERIA SCOREa 
Epidemiological criteria  
Stay in endemic area 2 
Occurrence in May–October 2 
Contact (certain or possible) with dog ticks 2 
Clinical criteria  
Fever > 39ºC 5 
Eschar 5 
Maculopapular or purpuric rash 5 
Two of the above criteria 3 
All three of the above criteria 5 
Non-specific laboratory findings  
Platelets < 150 G⁄L 1 
SGOT or SGPT > 50 U⁄L 1 
Bacteriological criteria  
Blood culture positive for Rickettsia conorii 25 
Detection of Rickettsia conorii in a skin biopsy 25 
Serological criteria  
Single serum and IgG > 1 ⁄ 128 5 
Single serum and IgG > 1 ⁄ 128 and IgM > 1 ⁄ 64 10 
Four-fold increase in two sera obtained within a 2-week interval 10 
SGOT, serum glutamate–oxaloacetate transaminase; SGPT, serum glutamate–pyruvate transaminase. 
aA positive diagnosis is made when the overall score is ≥ 25. 
Table 5. Diagnostic criteria for Mediterranean spotted fever caused by Rickettsia conorii 
8. Prophylaxis 
An important chapter in the field of rickettsioses is related to prophylaxis. Since the majority 
of rickettsioses associated to travels are transmitted by ticks, the main preventive measure is 
to avoid tick-bites. Measures to avoid chiggers’ attacks are the same as the ones used against 
ticks. Only fleas can be more difficult to avoid when cats and other pets are abundant. If 
there is risk of getting lice, hygiene measures such as changing clothing (they live in the 
seams of clothing) may be sufficient. 
How can we avoid tick-bites? There are some rules that can be useful to avoid arthropod-
bites: 
1. You must not wear dark clothes to see the ticks and remove them before attaching. 
Curiously, dark clothes attract less arthropods than clear ones. But, in our opinion, to 
look for the arthropods and remove them as soon as possible is more effective.  
2. For outdoor activities (grass areas or mountains) you do not have to exposure your 
body to ticks. Thus, it is very useful to wear clothing that covers the majority of your 
body. The trousers must be tucked in your shocks with boots. Long sleeves shirt must 
be tucked into trousers. You must also wear a cap (especially children). 
3. Permethrin-based repellents can be used on clothing, although their effect is short in 
time and the application should be repeated every few hours. 
4. A careful inspection of clothing and body looking for ticks after returning from 
outdoors activities in endemic areas as well as removing them correctly has been 
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effective for the prevention of Lyme disease. The tick needs at least 24-48 hours for the 
transmission of Borrelia burgdorferi. This measure can be less efficient for Rickettsia spp. 
because these microorganisms can be transmitted since the first hours. But, anyway, the 
removal of the tick has to be done. 
5. The contact with parasitized pets and wild animals must be avoided.  
There are two questions that physicians have linked up with tick-bites: How must I remove 
the tick? Must I take prophylactic drugs after a tick-bite? 
The first question is easy to answer. The most useful method to remove an attached tick is 
using forceps. Smooth forceps (without teeth) must be introduced between the tick’s head 
and the skin in a 90º angle and then pull (Oteo et al., 1996). Other traditional methods as 
using oil, burning or freezing must be forgotten. 
The other question is the use of prophylactic drugs after arthropod bites. There are no studies 
to answer this question. The transmission of rickettsias may be very quick, so we cannot 
extrapolate the recommendations for Lyme disease. Anyway, when people have been bitten 
by several ticks in an endemic area for a determinate disease (i.e.: Kruger National Park in 
South Africa and ATBF) and if the patient is anxious, we can offer doxycycline. It has been 
demonstrated that 3 doses of 100 mg. every 12 hours is safety and sufficient as treatment for 
the majority of rickettsioses. We must be cautious with the sun to avoid photo-sensibility. 
Children can take doxycycline for a short period of time. It is only contraindicated for 
pregnant women and in this case we can use macrolides (i.e.  azythromycin).  
Vaccine approaches for prevention of rickettsial diseases have been developed since the past 
century, but currently no vaccine is available. Major surface protein antigens (OmpA and 
OmpB) of R. rickettsii and R. conorii are candidate vaccine antigens. Molecular biology 
techniques such as selection, cloning and expression of genes encoding R. prowazekii 
virulence-associated proteins, offer the opportunity to develop new rickettsial vaccines 
against typhus group rickettsiae. Further research is needed to develop effective vaccines 
without undesirable toxic reactions (Azad & Radulovic, 2003; Walker, 2009).  
9. Treatment 
The treatment of rickettsiosis should be initiated as soon as possible. Antibiotics are very 
effective and may avoid severe complications and death. In all cases if rickettsiosis is 
suspected, samples should be sent for laboratory confirmation. In DEBONEL/TIBOLA, in 
which the clinical signs and symptoms are less severe, recovery without antimicrobials 
occurs but the use of antibiotics shortens the clinical course and improves the clinical picture 
(Ibarra et al., 2005). 
Doxycycline is the most useful drug in children and adults. Doxycycline can be 
administered in short course (100 mg. every 12 hours for one day) for the treatment of 
typhus and scrub typhus. In the case of MSF, 2 doses of 200 mg./12 hous are also very 
effective (in children, 5 mg./kg./12hours); although most physicians use 100 mg. every 12 
hours for 3-7 days after fever disappears. The same can be recommended for ATBF. This 
antibiotic regimen could probably be followed in other tick-borne rickettsioses but there are 
not good evidences (clinical assays) to support a recommendation. In RMSF the 
administration of doxycycline for 7 days is recommended. Other drugs that can be 
prescribed when not using doxycycline (allergy or pregnancy) are chloramphenicol (50-75 
mg./kg./day given in 4 doses for 7-10 days) and azythromycin (500 mg./day for 5 days). 
Doxycycline for 7 days is the treatment of choice for rickettsialpox. Although there is in vitro 
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susceptibility to quinolones, the use of these drugs has been associated with worse clinical 
course (Botelho-Nevers et al., 2011).  
10. Conclusion 
In conclusion, rickettsioses are a worldwide threat that must be suspected in travellers 
returning from endemic areas. Most cases are caused by tick-bites, although in some areas of 
the world old diseases as typhus are present, and the risk exists. Rickettsiosis must be 
suspected in all patients with fever, exanthema with or without rash. Starting treatment 
with doxycycline when possible may be essential to rapidly recover and avoid 
complications. ATBF along with malaria is the leading cause of fever after returning from 
Sub-Saharan Africa. 
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